Lackey Law Firm PC Announces Alicia Lackey Named 2025 Top Rated Austin Family Law Attorney by Super Lawyers 
Halvorsen Klote Davis Founding Attorneys Named to 2025 Super Lawyers List 
IC Group Holdings Inc. Announces 74 Percent Revenue Growth in Third Quarter 2025 
Sonim Technologies Files Preliminary Proxy Statement, Advancing Asset Purchase by NEXA Mobility 
Investors Look Beyond Public REITs as Interest in Private Real Estate and Alternatives Rises on Parvis Platform New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey
SALT LAKE CITY, Dec. 15, 2021 (GLOBE NEWSWIRE) — Now is the time when people…
Preclinical tasquinimod data presented at ASH 2021 available on Active Biotech’s website
Lund, December 15, 2021 – Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that preclinical data…
UPDATE – Y-mAbs Announces Pipeline Update
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Oyster Point Pharma Announces Addition To Nasdaq Biotechnology Index
PRINCETON, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Sanara MedTech Inc. Announces the Appointment of Roszell Mack III to its Board of Directors
FORT WORTH, TX, Dec. 15, 2021 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara” or the…
Y-mAbs Announces Pipeline Update
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Orpharm LLC for its Lead Asset, QRX003, for Netherton Syndrome
Orpharm Gains Exclusive Rights to Commercialize QRX003 in Russia and CIS ASHBURN, Va., Dec. 15,…
REPEAT – Tetra Bio-Pharma Announces Pricing of Marketed Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OTTAWA, Dec….
Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum
HOUSTON, Dec. 15, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
ABVC BioPharma Medical Device Vitargus Receives Taiwan National Innovation Award
Fremont, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
Allogene Therapeutics Expands Headquarters to Support Company Growth and Pipeline Innovation
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO),…
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress
Received feedback from the European notified body after review of Expanded IH submission Pleased with…
European Medicines Agency Grants Orphan Medicinal Product Designation for SCYNEXIS’ Innovative Antifungal Ibrexafungerp for the Indication of Invasive Candidiasis
Orphan medicinal product designation will provide at least 10 years of market exclusivity in the…
Skye Bioscience Expands Board of Directors with the Appointment of Life Sciences Executive Keith W. Ward, PhD
Skye Bioscience Announces Promotion of Tu Diep, MSc to Chief Development Officer SAN DIEGO, CA,…
Outlook Therapeutics to Present Pivotal Data from NORSE TWO Trial at the 9th International Congress on OCT and OCT Angiography in Rome (ICOOR)/ FLORetina Symposia
Francesco Bandello, MD, FEBO, will present Phase 3 pivotal safety and efficacy data from the…
CoImmune Announces Positive Results from Phase 1/2 Clinical Trial of Allogeneic CAR-CIK Cells in Pediatric and Adult Patients with Acute Lymphoblastic Leukemia
Oral presentation at 63rd ASH Annual Meeting & Exposition shows that treatment based on company’s…
Remix Therapeutics Appoints Zaven Kaprielian, Ph.D., as Chief Scientific Officer
Strengthens Leadership Team with Addition of Accomplished Research and Drug Discovery Executive CAMBRIDGE, Mass., Dec….
Windtree Announces U.S. Patent and Trademark Office Issuance of New U.S. Istaroxime Patent
New Patent Provides Intellectual Property Protection Through Late 2039 WARRINGTON, Pa., Dec. 15, 2021 (GLOBE…
Forever Healthy and the Buck Institute Announce Partnership to Advance Translational Research in Human Rejuvenation
— Michael Greve’s Forever Healthy Foundation commits $5 million to fund breakthrough science with strong potential for startup creation at…
Rogers Breaks Ground on Highway 16 Wireless Expansion in B.C.
Construction underway on first of 12 new towers that will help to close cell gaps…